Brett Cook is a Partner at F-Prime, where he focuses on investments in healthcare technology and service companies. At F-Prime, Brett has led or participated in our investments in Blue Rabbit (acquired by Wedgewood Pharmacy), Iora Health (acquired by One Medical), PatientPing (acquired by Appriss Heath), VitalWare (acquired by Health Catalyst), 1up Health, AppliedVR, BenchSci, Better Life Partners, Bluebird Kids Health, Equip, Expressable, NOCD, Notable, Paradigm Health, Proximie, Rippl, and Wellbeam, among others. While at F-Prime, and in collaboration with GV and the Broad Institute, Brett also helped launch and run Project Beacon, a social benefit organization that facilitated more than 1.5 million COVID tests for the Commonwealth of Massachusetts and K-12 schools.
Prior to rejoining F-Prime in 2018, Brett led the finance team at PatientPing (acquired by Appriss Health), a healthcare technology company providing real-time admission and discharge notifications to coordinate patient care. Previously, Brett worked at Aledade and McKinsey & Company.
Brett holds an M.B.A. from Harvard Business School and a B.S.E. in Biomedical Engineering from Duke University.
PharmEasy is one of India’s largest healthcare delivery platforms. The company helps patients connect with local pharmacy stores and diagnostic centers in order to fulfill their medical needs.
Notable is an AI powered healthcare company that puts appointments on autopilot. By analyzing historical patterns of practice, Notable proactively automates away hundreds of manual repetitive tasks like adding diagnoses, orders, templates, billing codes, and more.
Nebula Genomics is a human genome sequencing and health big data company on a mission to usher in the era of genomic sequencing by building a large and trusted genomic and health data marketplace for consumers, researchers and the medical community. Using blockchain to ensure that consumers maintain control of their data and are compensated for its use, the Nebula marketplace will aggregate a critical mass of rich genetic information that researchers can analyze in order to accelerate drug development, streamline clinical trials, and usher in the era of truly personalized medicine. Nebula Genomics was acquired by ProPhase Labs in 2021.
CareStack™ is a cloud-based platform that combines dental practice management, patient engagement and data analytics.
Centivo is a new type of self-funded health plan built specifically for employers and their employees and families. The Company targets zero healthcare trend and improved healthcare outcomes by rewarding members and providers for smart choices and actions while delivering an exceptional member experience. Centivo serves as a health plan or third-party administrator (TPA) for employers and partners closely with local health plans and TPAs to enhance their offerings.
Benchling is the industry-leading software platform for life science R&D. Purpose-built for biologics, Benchling combines an Electronic Lab Notebook (ELN), Laboratory Information Management System (LIMS), and a molecular biology design suite into a single, unified, cloud-based platform. It’s trusted by over 200,000 scientists — from pioneering academics and high-growth startups to all of the world’s top 50 biopharma companies.
Papaya Payments is a free and easy way to pay your bills. Just snap a photo of a paper bill and Papaya will automatically validate it and facilitate your payment.
Health Technology is a mobile platform for hospitals that connects patients, optimizes the patient’s hospital visit experience, and streamlines administrator workflow.
Wanhu provides integrated pharmacy benefit management services in China to better manage drug use and control costs.